Adaptimmune Therapeutics PLC: Scotiabank first releases industry outperforming market rating and target share price of $3.15
Adaptimmune Therapeutics PLC：丰业银行首次发布行业跑赢大盘评级和3.15美元的目标股价
Adaptimmune Therapeutics PLC: Scotiabank first releases industry outperforming market rating and target share price of $3.15
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.